**Core Concept**
The management of cervical cancer often involves radiation therapy, with point A being a reference point for dose delivery. **Radiation oncology** plays a crucial role in treating cervical cancer, especially in stages where surgical intervention is not feasible. The dose delivered to point A is critical for **tumor control** and minimizing **side effects**.

**Why the Correct Answer is Right**
The correct dose is typically around 70-90 Gy, considering both external beam radiation therapy (EBRT) and brachytherapy. **Brachytherapy** delivers a high dose to the tumor while sparing surrounding tissues, and when combined with EBRT, it achieves the desired cumulative dose at point A. This approach helps in **local control** of the tumor.

**Why Each Wrong Option is Incorrect**
**Option A:** This dose is too low for effective tumor control at point A.
**Option B:** Similarly, this is insufficient for the cumulative dose needed.
**Option D:** This exceeds the typical dose range, potentially increasing **toxicity**.

**Clinical Pearl / High-Yield Fact**
Remember, the dose at point A is critical, and **brachytherapy** is a key component in achieving the desired dose in cervical cancer treatment. The combination of EBRT and brachytherapy allows for a high dose to the tumor while minimizing damage to surrounding healthy tissues.

**Correct Answer:** D. 80-90 Gy